{"id":"https://openalex.org/W207518949","doi":null,"title":"Comparative in vitro Cytotoxicity of the Generic and Reference Products of Gemcitabine on Various Cancer Cell Lines","display_name":"Comparative in vitro Cytotoxicity of the Generic and Reference Products of Gemcitabine on Various Cancer Cell Lines","publication_year":2011,"publication_date":"2011-04-09","ids":{"openalex":"https://openalex.org/W207518949","mag":"207518949"},"language":"th","primary_location":{"id":"mag:207518949","doi":null,"is_oa":false,"landing_page_url":"https://www.tci-thaijo.org/index.php/SRIMEDJ/article/view/12738","pdf_url":null,"source":{"id":"https://openalex.org/S4306530813","display_name":"Srinagarind Medical Journal (SMJ) - \u0e28\u0e23\u0e35\u0e19\u0e04\u0e23\u0e34\u0e19\u0e17\u0e23\u0e4c\u0e40\u0e27\u0e0a\u0e2a\u0e32\u0e23","issn_l":"2821-9724","issn":["2821-9724"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Srinagarind Medical Journal (SMJ) - \u0e28\u0e23\u0e35\u0e19\u0e04\u0e23\u0e34\u0e19\u0e17\u0e23\u0e4c\u0e40\u0e27\u0e0a\u0e2a\u0e32\u0e23","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041543030","display_name":"Chariya Hahnvajanawong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chariya Hahnvajanawong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087300178","display_name":"Vajarabhongsa Bhudisawadi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vajarabhongsa Bhudisawadi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067849824","display_name":"Nisana Namwat","orcid":"https://orcid.org/0000-0002-6743-5047","observed_orcids":["https://orcid.org/0000-0002-6743-5047"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nisana Namwat","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6743-5047","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037244623","display_name":"Banchob Sripa","orcid":"https://orcid.org/0000-0001-8899-5919","observed_orcids":["https://orcid.org/0000-0001-8899-5919"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Banchob Sripa","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8899-5919","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5079921975","display_name":"Wichittra Tassaneeyakul","orcid":"https://orcid.org/0000-0001-6722-8796","observed_orcids":["https://orcid.org/0000-0001-6722-8796"]},"institutions":[{"id":"https://openalex.org/I179193067","display_name":"Khon Kaen University","ror":"https://ror.org/03cq4gr50","country_code":"TH","type":"education","lineage":["https://openalex.org/I179193067"]}],"countries":["TH"],"is_corresponding":false,"raw_author_name":"Wichittra Tassaneeyakul","raw_affiliation_strings":["Khon-Kaen University"],"raw_orcid":"https://orcid.org/0000-0001-6722-8796","affiliations":[{"raw_affiliation_string":"Khon-Kaen University","institution_ids":["https://openalex.org/I179193067"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8121,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.83461036,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"26","issue":"1","first_page":"2","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.5889000296592712,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.5889000296592712,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.06599999964237213,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.051899999380111694,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.996999979019165},{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.6420000195503235},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.8330000042915344},{"id":"https://openalex.org/keywords/ic50","display_name":"IC50","score":0.8700000047683716},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.7419999837875366},{"id":"https://openalex.org/keywords/cervical-cancer","display_name":"cervical cancer","score":0.6480000019073486},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.9819999933242798},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.6679999828338623},{"id":"https://openalex.org/keywords/pharmaceutical-quality-control","display_name":"pharmaceutical quality control","score":0.4950000047683716},{"id":"https://openalex.org/keywords/thailand","display_name":"Thailand","score":0.5139999985694885}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.9195579886436462},{"id":"https://openalex.org/C2776074239","wikidata":"https://www.wikidata.org/wiki/Q2452042","display_name":"Sulforhodamine B","level":4,"score":0.6967836618423462},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.6268202066421509},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.6191504001617432},{"id":"https://openalex.org/C2777366897","wikidata":"https://www.wikidata.org/wiki/Q847482","display_name":"HeLa","level":3,"score":0.598889172077179},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5895386934280396},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4435102939605713},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.4184529781341553},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3919335603713989},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.37275445461273193},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3548475503921509},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.33552539348602295},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.33543524146080017},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2278652787208557},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22360563278198242},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2107967734336853},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.14722642302513123},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1437099575996399},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:207518949","doi":null,"is_oa":false,"landing_page_url":"https://www.tci-thaijo.org/index.php/SRIMEDJ/article/view/12738","pdf_url":null,"source":{"id":"https://openalex.org/S4306530813","display_name":"Srinagarind Medical Journal (SMJ) - \u0e28\u0e23\u0e35\u0e19\u0e04\u0e23\u0e34\u0e19\u0e17\u0e23\u0e4c\u0e40\u0e27\u0e0a\u0e2a\u0e32\u0e23","issn_l":"2821-9724","issn":["2821-9724"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Srinagarind Medical Journal (SMJ) - \u0e28\u0e23\u0e35\u0e19\u0e04\u0e23\u0e34\u0e19\u0e17\u0e23\u0e4c\u0e40\u0e27\u0e0a\u0e2a\u0e32\u0e23","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W168326817","https://openalex.org/W1561951079","https://openalex.org/W2096592088","https://openalex.org/W2097968583","https://openalex.org/W2115261608","https://openalex.org/W2132066721","https://openalex.org/W2188928518","https://openalex.org/W2284799106","https://openalex.org/W2547272920"],"related_works":["https://openalex.org/W2096592088","https://openalex.org/W1561951079","https://openalex.org/W7008215103","https://openalex.org/W7095796941","https://openalex.org/W2992605291","https://openalex.org/W2074421134","https://openalex.org/W2054849742","https://openalex.org/W1982829475","https://openalex.org/W7098726149","https://openalex.org/W2234785744"],"abstract_inverted_index":{"Background":[0],"and":[1,52,153,249,261,282,321,356],"objectives":[2],":":[3,125,230,342],"Gemcitabine":[6],"is":[7],"a":[8],"chemotherapeutic":[9],"agent":[10],"which":[11],"can":[12],"be":[13],"used":[14,131],"for":[15,35,310],"the":[16,53,61,69,85,92,117,133,154,174,196,202,212,216,252,264,305,311,322,371,381,387,406],"treatment":[17,36],"of":[18,37,45,55,72,91,164,180,198,206,211,272,370,379,412],"several":[19,42,75],"cancers.":[20],"Recent":[21],"clinical":[22],"studies":[23],"demonstrated":[24],"that":[25,405],"gemcitabine":[26,46,73,94,165,236],"alone":[27],"or":[28],"in":[29,50,87,116,132,239,386,408],"combination":[30],"with":[31,107,215,251],"cisplatin":[32],"are":[33,47,58,420],"effective":[34],"cholangiocarcinoma":[38],"(CCA).\u00a0":[39],"To":[40],"date,":[41],"generic":[43,93,213,372],"products":[44,57,274,415],"now":[48],"available":[49],"Thailand":[51],"price":[54],"these":[56,167,273,333,413],"lower":[59],"than":[60],"reference":[62,109,217,323,396],"product.\u00a0":[63],"This":[64,403],"study":[65,135],"aimed":[66],"to":[67,83,183,235,295,363],"determine":[68],"cytotoxic":[70,270],"activity":[71],"on":[74,166,275,332,416],"human":[76,243,346],"cancer":[77,144,149,156,168,277,280,284,334,347,355,358,382,417,440],"cell":[78,129,138,145,150,157,169,185,199,245,267,286,335,348,359,383,418,441],"lines":[79,130,139,170,287,336,349,360,384,419,442],"as":[80,82],"well":[81],"compare":[84],"vitro":[88,409],"cytotoxicity":[90,411],"product":[95,110,214,218,313,324],"(Gemita":[96,314],"\u00ae":[97,112,317,328,376,400,434,437],",":[98,113,378,435,438],"Fresenius":[99],"Kabi":[100],"Oncology":[101],"Ltd.;":[102],"formerly\u00a0":[103],"Dabur":[104],"Pharma":[105],"Ltd.)":[106],"its":[108,395],"(Gemzar":[111,325],"Eli":[114],"Lilly)":[115],"similar":[118,290],"experimental":[119],"conditions.":[120],"Methods":[124],"Cancer":[128],"present":[134,388],"were":[136,219,237,288,302,361,390],"CCA":[137,244],"(KKU-M055,":[140],"KKU-M213,":[141],"KKU-M214),":[142],"cervical":[143,276,352],"line":[146,151,158],"(HeLa),":[147,278],"colon":[148,279,354],"(SW620)":[152,281],"lung":[155,283,357],"(A549).":[159],"The":[160,178,269,365],"growth":[161],"inhibitory":[162],"effect":[163],"was":[171,192,263],"measured":[172],"by":[173,187,194],"sulforhodamine":[175],"B":[176],"assay.\u00a0":[177],"concentration":[179],"drug":[181,203],"required":[182],"inhibit":[184],"proliferation":[186],"50%":[188],"(IC":[189,291],"50":[190,208,254,292,307,367],")":[191,320,331],"determined":[193],"plotting":[195],"percentage":[197],"viability":[200],"versus":[201],"concentrations.":[204],"Comparisons":[205],"IC":[207,253,306,366],"values":[210,256,309,369],"analyzed":[220],"using":[221],"independent":[222],"t":[224],"-test.":[225],"Results":[229],"\u00a0The":[233],"sensitivities":[234],"varied":[238],"the\u00a0":[240],"3":[241],"different":[242,393],"lines,":[246],"KKU-M055,":[247],"KKU-M213":[248],"KKU-M214,":[250],"ranging":[257],"from":[258,394],"52-1,832":[259],"nM":[260],"KKU-M055":[262],"most":[265],"sensitive":[266,362],"line.":[268],"effects":[271],"(A549)":[285],"very":[289],"13.44":[294],"22.97":[296],"nM).\u00a0":[297],"No":[298],"statistically":[299],"significant":[300,423],"differences":[301],"found":[303],"between":[304],"test":[312],"(p>0.05).":[337],"Conclusions":[341],"Several":[345],"including":[350],"CCA,":[351],"cancer,":[353],"gemcitabine.\u00a0":[364],"product,":[373,397],"Gemita":[374,433],"all":[380],"tested":[385],"study,":[389],"not":[391,421],"significantly":[392],"Gemzar":[398,436],".":[401],"suggests":[404],"two":[414],"statistical":[422],"different.":[424],"Key":[429],"words:":[430],"Gemcitabine,":[432],"Human":[439]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-07-28T07:46:37.118299","created_date":"2016-06-24T00:00:00"}